Bush Opposes Adding Biologic Generics To FDA Bill

Law360, New York (May 1, 2007, 12:00 AM EDT) -- The White House on Tuesday expressed firm opposition to any attempt to add a law that would pave the way for generic or follow-on drugs to be approved to a bill allowing the Food and Drug Administration to collect fees, which is currently being debated in the U.S. Senate.

“While some in Congress may be interested in attaching legislation related to follow-on protein products to this bill, the Administration believes that these complex issues should be considered thoroughly through a robust scientific, regulatory and legal discussion,”...
To view the full article, register now.